Free Trial
ASX:FTT

Factor Therapeutics (FTT) Stock Price, News & Analysis

About Factor Therapeutics Stock (ASX:FTT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
425,600 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FTT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Factor Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

FTT Stock News Headlines

Anatara Lifesciences Limited (ANR.AX) Chair Transition
See More Headlines

FTT Stock Analysis - Frequently Asked Questions

Factor Therapeutics Limited (ASX:FTT) released its quarterly earnings data on Thursday, August, 8th. The biotechnology company reported $0.00 earnings per share for the quarter.

Company Calendar

Last Earnings
8/08/2019
Today
7/14/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:FTT
Previous Symbol
ASX:TIS
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
19.84
Quick Ratio
19.76

Sales & Book Value

Annual Sales
A$1.79 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
1.00
Book Value
A$0.03 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
104,284,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (ASX:FTT) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners